Internet-guided Cognitive Behavioural Therapy to Improve Depression Patients With Cardiovascular Disease
1 other identifier
interventional
144
1 country
1
Brief Summary
Purpose and aims Tailored internet-based cognitive behavioural therapy (I-CBT) is a new innovative and person-centred method that is promising that may be used to decrease depression in patients with cardiovascular disease (CVD). In patients with CVD, depressive symptoms is a common co-morbidity leading to decreased wellbeing, and increased morbidity and mortality. Depressive symptoms are both underdiagnosed and undertreated in CVD patients. Earlier studies have demonstrated the efficiency of cognitive behavioural therapy (CBT) for many psychiatric conditions, but few studies have evaluated CBT in patients with CVD. The overall purpose of this study is to evaluate the effects of the tailored I-CBT program on reducing depressive symptoms and other patient reported outcomes in patients with cardiovascular disease (CVD) and to explore factors related to implementation of the I-CBT program in clinical cardiac care. The primary aim:
- To evaluate the effects of the tailored I-CBT depression program on depressive symptoms. Secondary aims:
- To evaluate effects on quality of life´, sleep and anxiety
- To evaluate factors that can influence the I-CBT programs effect on depressive symptoms.
- To gain knowledge about the I-CBT program, as perceived by patients and health care professionals.
- To explore facilitators and barriers to the implementation of the I-CBT program in clinical practice from the perspectives of patients, health care professionals and policymakers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2016
CompletedFirst Posted
Study publicly available on registry
May 19, 2016
CompletedStudy Start
First participant enrolled
February 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedResults Posted
Study results publicly available
November 27, 2019
CompletedDecember 11, 2019
November 1, 2019
1.4 years
May 16, 2016
September 24, 2019
November 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Depressive Symptoms Collected With the Patient Health Questionnaire-9 (PHQ-9)
The PHQ-9 is a nine-item instrument for measurement of depressive symptoms during the last two weeks. Each item is answered on a four graded scale where zero represents that the item do not affect the person and numbers one to three represents that the item affects the person several days to almost every day. The answers are summed to a total sum score, range 0-27, with higher numbers representing higher level of depressive symptoms. A cut off \>5 represents minor depression and a cut off \>10 represents major depression
Score at 9 weeks follow-up
Study Arms (2)
Internet Cognitive Behavioural Therapy
EXPERIMENTALParticipants will perform a nine-week tailored I-CBT program developed to fit CVD patients. The program consists of psychoeducation, relaxation, problem-solving and behavioral activation.
Moderated discussion forum
PLACEBO COMPARATORIn this arm the participants are allocated to a non mandatory discussion forum for nine weeks. Evert week will participants discuss issues regarding their CVD. Themes discussed are suggested by the study team, and a new theme is added every week. A moderator from the study group act as a supervisor and checks that issues discussed are ok. After the nine week discussion forum the participants are offered the nine week CBT program.
Interventions
A nine-week tailored I-CBT program for patients with CVD. The CBT program consists of the components of psychoeducation, relaxation, problem-solving and behavioural activation.
Participants will be allocated to an internet moderated discussion forum during 9 weeks. Patients will discuss issues related to cardiovascular disease. A new topic will be discussed every week. After 9 weeks, those in the moderated discussion forum will be offered to perform the I-CBT program.
Eligibility Criteria
You may qualify if:
- treatment for CVD according to European Society of Cardiology guidelines.
- stable CVD (NYHA class I-III) and not having been hospitalised for CVD in in the last four weeks.
- depressive symptoms (Patient Health Questionnaire-9 17 (PHQ-9) \> 5 points)
You may not qualify if:
- severe CVD (NYHA IV) or another severe chronic life-threatening disease
- severe depression assessed as requiring acute treatment
- not being able to dedicate 3-4 hours to participate in the program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Linkoping University
Norrköping, 601 74, Sweden
Related Publications (6)
Mourad G, Lundgren J, Andersson G, Johansson P. Healthcare use in patients with cardiovascular disease and depressive symptoms - The impact of a nurse-led internet-delivered cognitive behavioural therapy program. A secondary analysis of a RCT. Internet Interv. 2023 Dec 5;35:100696. doi: 10.1016/j.invent.2023.100696. eCollection 2024 Mar.
PMID: 38093803DERIVEDWestas M, Mourad G, Andersson G, Lundgren J, Johansson P. The effects of internet-based cognitive behaviour therapy for depression in cardiovascular disease on symptoms of anxiety: a secondary analysis of a randomized trial. Eur J Cardiovasc Nurs. 2024 May 28;23(4):382-390. doi: 10.1093/eurjcn/zvad097.
PMID: 37740442DERIVEDJohansson P, Lundgren J, Andersson G, Svensson E, Mourad G. Internet-Based Cognitive Behavioral Therapy and its Association With Self-efficacy, Depressive Symptoms, and Physical Activity: Secondary Analysis of a Randomized Controlled Trial in Patients With Cardiovascular Disease. JMIR Cardio. 2022 Jun 3;6(1):e29926. doi: 10.2196/29926.
PMID: 35657674DERIVEDMourad G, Lundgren J, Andersson G, Husberg M, Johansson P. Cost-effectiveness of internet-delivered cognitive behavioural therapy in patients with cardiovascular disease and depressive symptoms: secondary analysis of an RCT. BMJ Open. 2022 Apr 11;12(4):e059939. doi: 10.1136/bmjopen-2021-059939.
PMID: 35410939DERIVEDWestas M, Lundgren J, Andersson G, Mourad G, Johansson P. Effects of Internet-delivered cognitive behavioural therapy adapted for patients with cardiovascular disease and depression: a long-term follow-up of a randomized controlled trial at 6 and 12 months posttreatment. Eur J Cardiovasc Nurs. 2022 Aug 29;21(6):559-567. doi: 10.1093/eurjcn/zvab131.
PMID: 35061868DERIVEDJohansson P, Westas M, Andersson G, Alehagen U, Brostrom A, Jaarsma T, Mourad G, Lundgren J. An Internet-Based Cognitive Behavioral Therapy Program Adapted to Patients With Cardiovascular Disease and Depression: Randomized Controlled Trial. JMIR Ment Health. 2019 Oct 3;6(10):e14648. doi: 10.2196/14648.
PMID: 31584000DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Peter Johansson
- Organization
- Linkoping University
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Johansson, PhD
Department of Social and Welfare Studies, Linköping University, Norrköping, Sweden
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- RN, PhD, Professor
Study Record Dates
First Submitted
May 16, 2016
First Posted
May 19, 2016
Study Start
February 6, 2017
Primary Completion
June 30, 2018
Study Completion
June 30, 2019
Last Updated
December 11, 2019
Results First Posted
November 27, 2019
Record last verified: 2019-11